Protecting Clinicians from Hazardous Drug Exposures

Recorded On: 01/19/2022


The National Institute for Occupational Safety and Health (NIOSH) provides an ongoing, continually revised list of drugs and biologic agents that meet the definition of hazardous drugs (HDs). Clinicians who prepare and administer hazardous drugs are potentially at risk by direct and indirect contact. Safe handling requirements, by the Occupational Safety and Health Administration (OSHA), NIOSH, USP 800, and INS 2021 Infusion Therapy Standards of Practice (SOPs), provide guidance to protect clinicians from hazardous drug exposure. Specifically, NIOSH recommends health care workers use a close system transfer device (CSTD) throughout the hazardous drug-handling chain, from drug compounding to administration. In this presentation, we will define hazardous drugs and clinician risk, discuss various safety requirements, evaluate various CSTDs, and learn to apply the INS 2021 SOPs into practice. 

Learning Objectives: At the conclusion of this session, attendees will be able to:

·      Define hazardous drugs and clinician exposure risk

·      Verbalize various regulatory safety requirements, including OSHA, NIOSH, and USP 800

·      Evaluate various CSTDs for protective features

·      Apply into practice INS 2021 Infusion Therapy Standard of Practice #15: Hazardous Drugs and Waste

Seth Eisenberg, RN, ASN, OCN®, BMTCN™

Professional Practice Coordinator, Infusion Services

Seattle Cancer Care Alliance

Seth Eisenberg has been practicing in the field of oncology since 1983. His experience includes 35 years in bone marrow transplantation and 25 years in ambulatory oncology infusion. He has published numerous articles on chemotherapy and biotherapy, five book chapters, is as a contributing author to the Oncology Nursing Society (ONS) Safe Handling of Hazardous Drugs, and has presented nationally and internationally at nursing and pharmacy conferences. He received the 2017 March of Dimes research advancement award, the 2018 ONS Susan Baird Excellence in Clinical Writing Award, and the 2021 ONS Distinguished Award for Consistent Contribution to Nursing Literature.

CRNI® RUs: This session has been approved for 2 CRNI® recertification unit and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: January 19, 2025

To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.


Protecting Clinicians from Hazardous Drug Exposures
Live event: 01/19/2022 at 1:00 PM (EST) You must register to access.
Webinar Evaluation
Printable Certificate You must register to access.